肝細胞癌診断におけるproliferating cell nuclear antigenの有用性 生検肝標本による免疫組織化学的検討

書誌事項

タイトル別名
  • Proliferating cell nuclear antigen in hepatocellular carcinoma. A study with fine needle biopsy specimens.
  • 生検肝標本による免疫組織化学的検討

この論文をさがす

抄録

In an attempt to evaluate the proliferative activity of hepatocellular carcinoma (HCC) cells, we immunohistochemically examined the expression of proliferating cell nuclear antigen (PCNA) using specimens obtained with ultrasonography-guided fine needle biopsy. The labeling index (LI) of PCNA in HCC was significantly higher (22.3±6.3%, n=33; p<0.001) than in CH (10.2±2.7%, n=22) or LC (10.2±2.5%, n=25). Apparent increase in LI (>15.4%: mean±2SD of the controls) was observed in 88.6% in HCC (31/35 nodules), 4.5% in CH (1/22) and 4.0% in LC (1/25). Of 33 patients with increased LI (>15.4%), 31 (93.3%) had HCC. Nineteen of 20 small HCC (95.0%) with diameter of 20mm and under also showed LI exceeding 15.4%. In HCC patients, LI of cancerous lesion was significantly higher (23.9±4.6%; p<0.01) than that of non-cancerous lesion (10.8±3.9%). We conclude that PCNA is a reliable marker to assess the cell proliferative activity of HCC specimens obtained with fine needle biopsy.

収録刊行物

  • 肝臓

    肝臓 35 (6), 424-430, 1994

    一般社団法人 日本肝臓学会

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ